Amperos Health secured $16M in Series A funding and unveiled its AI-native denial management solution.
- Amount
- $16M
- Stage
- Series A
- Announced
- 22 April 2026
- Lead
- Bessemer Venture Partners
- Other investors
- Uncork Capital, Neo
- Use of funds
- Accelerate growth, expand analytics capabilities, and launch agentic capabilities in other RCM workflows.
- Total raised
- $21M to date
- Checked
- Amount and date checked against the press source